04:43 PM EDT, 05/21/2025 (MT Newswires) -- CEL-SCI ( CVM ) said Wednesday it plans to offer to sell shares, and/or pre-funded warrants, in an underwritten public offering.

All of the shares, and/or warrants, are being offered by the company, it said.

The offering is subject to market conditions and there's no assurance as to whether or when it may be completed, or as to its size or terms, CEL-SCI ( CVM ) said.

Net proceeds will be used to fund the development of Multikine, as well as for general corporate purposes, and working capital, the company said.

The company's shares were falling nearly 12% in recent after-hours activity.